Istituto per la Ricerca e l'Innovazione Biomedica
Quick facts
Marketed products
- Nebulized beclomethasone dipropionate · Respiratory
Beclomethasone dipropionate is a corticosteroid that suppresses airway inflammation by binding to glucocorticoid receptors and reducing inflammatory mediator production. - Resveratrol plus Carboxymethyl-β-Glucan · Immunology / Wellness
Resveratrol and carboxymethyl-β-glucan work synergistically to provide antioxidant and immunomodulatory effects. - Symbicort Turbohaler without Turbo+ · Respiratory
Symbicort combines an inhaled corticosteroid (budesonide) and a long-acting beta-2 agonist (formoterol) to reduce airway inflammation and improve bronchial smooth muscle relaxation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Istituto per la Ricerca e l'Innovazione Biomedica portfolio CI brief
- Istituto per la Ricerca e l'Innovazione Biomedica pipeline updates RSS
Frequently asked questions about Istituto per la Ricerca e l'Innovazione Biomedica
What are Istituto per la Ricerca e l'Innovazione Biomedica's marketed drugs?
Top marketed products include Nebulized beclomethasone dipropionate, Resveratrol plus Carboxymethyl-β-Glucan, Symbicort Turbohaler without Turbo+.
Related
- Nebulized beclomethasone dipropionate · Respiratory
- Resveratrol plus Carboxymethyl-β-Glucan · Immunology / Wellness
- Symbicort Turbohaler without Turbo+ · Respiratory
- Sector hub: All tracked pharma companies